Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines

Details for Australian Patent Application No. 2002361990 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Lang, Hans-Jochen; Hofmeister, Armin; Heinelt, Uwe; Wirth, Klaus

Agent Watermark

Pub. Number AU-B-2002361990

PCT Number PCT/EP02/13921

PCT Pub. Number WO2003/053434

Priority 101 63 239.8 21.12.01 DE

Filing date 9 December 2002

Wipo publication date 9 July 2003

Acceptance publication date 9 October 2008

International Classifications

C07D 233/06 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4168 (2006.01)

A61K 31/4184 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 33/00 (2006.01) Antiparasitic agents

A61P 33/14 (2006.01) Antiparasitic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 233/50 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 235/02 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 235/30 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): 101 63 239.8 21.12.01 DE

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2002361990

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

18 May 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 May 2006 Corrigenda

  Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2002 Delete all reference to Application No. 2002361990

9 October 2008 Application Accepted

  Published as AU-B-2002361990

5 February 2009 Standard Patent Sealed

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002361991-METHOD AND SYSTEM FOR DETERMINING INFORMATION ASSOCIATED WITH AN OBJECT

2002361989-N,N'-DISUBSTITUTED PIPERAZINE COMPOUNDS AND THE USE OF THE SAME AS ANALGESICS